Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Evan R. Goldfischer, MD, MBA, FACS

Advertisement

Articles by Evan R. Goldfischer, MD, MBA, FACS

whyframeshot - stock.adobe.com

Chronic care management in the urologic oncology setting

ByEvan R. Goldfischer, MD, MBA, FACS
September 25th 2020

CCM programs can engage multiple providers to care for patients while reducing in-person visits.

Advertisement

Latest Updated Articles

  • whyframeshot - stock.adobe.com
    Chronic care management in the urologic oncology setting

    Published: September 25th 2020 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones

2

Study launches of MRI plus PSMA-PET imaging for prostate cancer detection

3

CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction

4

John Sfakianos, MD, on moving immunotherapy earlier in NMIBC treatment pathway

5

Evaluating genetic counseling uptake in safety-net prostate cancer care

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us